Given its role in cancer progression, PAGA presents a potential target for therapeutic intervention. Strategies to counteract PAGA include the development of drugs that can restore normal apoptotic processes or specifically target the aberrant pathways involved. Researchers are exploring various approaches, such as small molecule inhibitors, monoclonal antibodies, and gene therapy, to target the molecular components of PAGA.
